Compounds > deoxyglucose
Page last updated: 2024-09-02

deoxyglucose and ER-Negative PR-Negative HER2-Negative Breast Cancer

deoxyglucose has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (44.44)24.3611
2020's5 (55.56)2.80

Authors

AuthorsStudies
Bizjak, M; Gole, B; Magnes, C; Pavlin, M; Potočnik, U; Repas, J; Zügner, E1
Büsselberg, D; Samuel, SM; Satheesh, NJ; Triggle, CR; Varghese, E1
Kim, AMJ; Kim, B; Lim, SO; Oh, W; Schwarz, JR; Sun, R1
Bamezai, RN; Chattopadhyay, S; Iqbal, MA; Khan, A; Prakasam, G; Siddiqui, FA; Siddiqui, S; Sultana, S; Ur Rehman, A1
Cui, Y; Gao, Q; Huang, Z; Liu, S; Song, W; Sun, Z1
Emons, G; Gründker, C; Hellriegel, M; Wokoun, U1
Martinez, VG; McNamee, N; O'Driscoll, L; O'Neill, S; Porter, RK1
Feng, X; Liu, Q; Mai, B; Wang, P; Wang, X; Zhang, T1
Imamura, H; Ogasawara, S; Okamoto, K; Tanaka, Y; Tsuneoka, M; Yano, H; Yoshioka, S1

Other Studies

9 other study(ies) available for deoxyglucose and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
Metabolic profiling of attached and detached metformin and 2-deoxy-D-glucose treated breast cancer cells reveals adaptive changes in metabolome of detached cells.
    Scientific reports, 2021, 11-01, Volume: 11, Issue:1

    Topics: Cell Line, Tumor; Cell Proliferation; Deoxyglucose; Female; Humans; Hypoglycemic Agents; Metabolome; Metabolomics; Metformin; Triple Negative Breast Neoplasms

2021
Metabolic heterogeneity in TNBCs: A potential determinant of therapeutic efficacy of 2-deoxyglucose and metformin combinatory therapy.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 164

    Topics: Cell Line, Tumor; Cell Proliferation; Deoxyglucose; Female; Glucose; Humans; Metformin; TOR Serine-Threonine Kinases; Triple Negative Breast Neoplasms

2023
Saccharide analog, 2-deoxy-d-glucose enhances 4-1BB-mediated antitumor immunity via PD-L1 deglycosylation.
    Molecular carcinogenesis, 2020, Volume: 59, Issue:7

    Topics: Animals; Antibodies; Antineoplastic Agents; B7-H1 Antigen; Cell Line; Cell Line, Tumor; Deoxyglucose; Female; Gefitinib; Glucose; HEK293 Cells; Humans; Immunotherapy; Mice; Mice, Inbred BALB C; Triple Negative Breast Neoplasms

2020
Silibinin induces metabolic crisis in triple-negative breast cancer cells by modulating EGFR-MYC-TXNIP axis: potential therapeutic implications.
    The FEBS journal, 2021, Volume: 288, Issue:2

    Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Databases, Genetic; Datasets as Topic; Deoxyglucose; Drug Synergism; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Glycolysis; Humans; Metabolome; Paclitaxel; Proto-Oncogene Proteins c-myc; Signal Transduction; Silybin; Survival Analysis; Triple Negative Breast Neoplasms

2021
A GLUT1 inhibitor-based probe significantly ameliorates the sensitivity of tumor detection and diagnostic imaging.
    Chemical communications (Cambridge, England), 2021, Jun-03, Volume: 57, Issue:45

    Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Biocompatible Materials; Biomarkers, Tumor; Cell Line, Tumor; Cell Membrane Permeability; Deoxyglucose; Fluorescent Dyes; Glucose Transporter Type 1; Humans; Mice; Multimodal Imaging; Neoplasms, Experimental; Optical Imaging; Positron-Emission Tomography; Triple Negative Breast Neoplasms

2021
Co-treatment of breast cancer cells with pharmacologic doses of 2-deoxy-D-glucose and metformin: Starving tumors.
    Oncology reports, 2017, Volume: 37, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxyglucose; Dose-Response Relationship, Drug; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Glycolysis; Humans; Membrane Potential, Mitochondrial; Metformin; Poly(ADP-ribose) Polymerases; Triple Negative Breast Neoplasms

2017
2-Deoxy-D-Glucose inhibits aggressive triple-negative breast cancer cells by targeting glycolysis and the cancer stem cell phenotype.
    Scientific reports, 2019, 03-07, Volume: 9, Issue:1

    Topics: Anoikis; Cell Line, Tumor; Cell Movement; Citrate (si)-Synthase; Deoxyglucose; Female; Glycolysis; Humans; Mitochondria; Neoplastic Stem Cells; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Triple Negative Breast Neoplasms; Voltage-Dependent Anion Channel 1

2019
Glycolytic inhibitors 2-deoxyglucose and 3-bromopyruvate synergize with photodynamic therapy respectively to inhibit cell migration.
    Journal of bioenergetics and biomembranes, 2015, Volume: 47, Issue:3

    Topics: Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Survival; Deoxyglucose; Drug Synergism; Fluorescent Antibody Technique; Glycolysis; Humans; Microscopy, Electron, Scanning; Photochemotherapy; Pyruvates; Tetrazolium Salts; Thiazoles; Triple Negative Breast Neoplasms

2015
Mild Glucose Starvation Induces KDM2A-Mediated H3K36me2 Demethylation through AMPK To Reduce rRNA Transcription and Cell Proliferation.
    Molecular and cellular biology, 2015, Volume: 35, Issue:24

    Topics: AMP-Activated Protein Kinases; Cell Line, Tumor; Cell Proliferation; Deoxyglucose; DNA Methylation; F-Box Proteins; Glucose; Glycolysis; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; MCF-7 Cells; Pol1 Transcription Initiation Complex Proteins; Promoter Regions, Genetic; RNA Interference; RNA, Ribosomal; RNA, Small Interfering; Starvation; Transcription, Genetic; Triple Negative Breast Neoplasms

2015